174 related articles for article (PubMed ID: 11355274)
21. Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease.
Money SR; Herd JA; Isaacsohn JL; Davidson M; Cutler B; Heckman J; Forbes WP
J Vasc Surg; 1998 Feb; 27(2):267-74; discussion 274-5. PubMed ID: 9510281
[TBL] [Abstract][Full Text] [Related]
22. Long-term safety of cilostazol in patients with peripheral artery disease: the CASTLE study (Cilostazol: A Study in Long-term Effects).
Hiatt WR; Money SR; Brass EP
J Vasc Surg; 2008 Feb; 47(2):330-336. PubMed ID: 18155871
[TBL] [Abstract][Full Text] [Related]
23. Cilostazol for peripheral arterial disease.
Robless P; Mikhailidis DP; Stansby GP
Cochrane Database Syst Rev; 2007 Jan; (1):CD003748. PubMed ID: 17253494
[TBL] [Abstract][Full Text] [Related]
24. Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial.
Dawson DL; Cutler BS; Meissner MH; Strandness DE
Circulation; 1998 Aug; 98(7):678-86. PubMed ID: 9715861
[TBL] [Abstract][Full Text] [Related]
25. Comparative effects of cilostazol and other therapies for intermittent claudication.
Dawson DL
Am J Cardiol; 2001 Jun; 87(12A):19D-27D. PubMed ID: 11434896
[TBL] [Abstract][Full Text] [Related]
26. Cilostazol in intermittent claudication.
Cariski AT; Lindmayer K
Am J Health Syst Pharm; 2002 Jan; 59(1):81-2. PubMed ID: 11813475
[No Abstract] [Full Text] [Related]
27. A phase II dose-ranging study of the phosphodiesterase inhibitor K-134 in patients with peripheral artery disease and claudication.
Brass EP; Cooper LT; Morgan RE; Hiatt WR
J Vasc Surg; 2012 Feb; 55(2):381-389.e1. PubMed ID: 22119244
[TBL] [Abstract][Full Text] [Related]
28. Cilostazol (pletal): a dual inhibitor of cyclic nucleotide phosphodiesterase type 3 and adenosine uptake.
Liu Y; Shakur Y; Yoshitake M; Kambayashi Ji J
Cardiovasc Drug Rev; 2001; 19(4):369-86. PubMed ID: 11830753
[TBL] [Abstract][Full Text] [Related]
29. Cilostazol for peripheral arterial disease.
Robless P; Mikhailidis DP; Stansby GP
Cochrane Database Syst Rev; 2008 Jan; (1):CD003748. PubMed ID: 18254032
[TBL] [Abstract][Full Text] [Related]
30. The effect of withdrawal of drugs treating intermittent claudication.
Dawson DL; DeMaioribus CA; Hagino RT; Light JT; Bradley DV; Britt KE; Charles BE
Am J Surg; 1999 Aug; 178(2):141-6. PubMed ID: 10487267
[TBL] [Abstract][Full Text] [Related]
31. [Cilostazol is effective and safe option for the treatment of intermittent claudication. Results of the NOCLAUD study].
Farkas K; Járai Z; Kolossváry E
Orv Hetil; 2017 Jan; 158(4):123-128. PubMed ID: 28116935
[TBL] [Abstract][Full Text] [Related]
32. Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication.
Stevens JW; Simpson E; Harnan S; Squires H; Meng Y; Thomas S; Michaels J; Stansby G
Br J Surg; 2012 Dec; 99(12):1630-8. PubMed ID: 23034699
[TBL] [Abstract][Full Text] [Related]
33. Effects of cilostazol on lipid and fatty acid metabolism.
Nakamura N; Osawa H; Yamabe H; Okumura K; Hamazaki T
Clin Exp Med; 2005 Mar; 4(4):170-3. PubMed ID: 15750763
[TBL] [Abstract][Full Text] [Related]
34. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials.
Hood SC; Moher D; Barber GG
CMAJ; 1996 Oct; 155(8):1053-9. PubMed ID: 8873633
[TBL] [Abstract][Full Text] [Related]
35. Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudication.
Elam MB; Heckman J; Crouse JR; Hunninghake DB; Herd JA; Davidson M; Gordon IL; Bortey EB; Forbes WP
Arterioscler Thromb Vasc Biol; 1998 Dec; 18(12):1942-7. PubMed ID: 9848888
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological treatment of intermittent claudication does not have a significant effect on gait impairments during claudication pain.
Yentes JM; Huisinga JM; Myers SA; Pipinos II; Johanning JM; Stergiou N
J Appl Biomech; 2012 May; 28(2):184-91. PubMed ID: 22723116
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the cilostazol safety database.
Pratt CM
Am J Cardiol; 2001 Jun; 87(12A):28D-33D. PubMed ID: 11434897
[TBL] [Abstract][Full Text] [Related]
38. Treatment of intermittent claudication with pentoxifylline and cilostazol.
Tjon JA; Riemann LE
Am J Health Syst Pharm; 2001 Mar; 58(6):485-93; quiz 494-6. PubMed ID: 11286146
[TBL] [Abstract][Full Text] [Related]
39. Treatment of intermittent claudication: cilostazol.
Collins P; Brittenden J
Hosp Med; 2004 Aug; 65(8):466-70. PubMed ID: 15330347
[TBL] [Abstract][Full Text] [Related]
40. The role of cilostazol in the treatment of intermittent claudication.
Barnett AH; Bradbury AW; Brittenden J; Crichton B; Donnelly R; Homer-Vanniasinkam S; Mikhailidis DP; Stansby G
Curr Med Res Opin; 2004 Oct; 20(10):1661-70. PubMed ID: 15462700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
